Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial.
Shuo WuLiang ZhangHuan LiJunnan XuCui JiangTao SunPublished in: Trials (2020)
ClinicalTrials.gov: NCT03932526. Registered on 30 April 2019.